This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
KDM4C-mediated senescence defense is a targetable vulnerability in gastric cancer harboring TP53 mutations
Clinical Epigenetics Open Access 17 October 2023
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Original article
Chibaya, L. et al. EZH2 inhibition remodels the inflammatory senescence-associated secretory phenotype to potentiate pancreatic cancer immune surveillance. Nat. Cancer https://doi.org/10.1038/s43018-023-00553-8 (2023)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bordon, Y. Combining EZH2 inhibition with senescence induction helps immune cells fight pancreatic cancer. Nat Rev Immunol 23, 411 (2023). https://doi.org/10.1038/s41577-023-00898-2
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41577-023-00898-2
This article is cited by
-
KDM4C-mediated senescence defense is a targetable vulnerability in gastric cancer harboring TP53 mutations
Clinical Epigenetics (2023)